Access to medicines & COVID-19: amplifying our message together

Wemos collaborates with other organisations to make our (joint) messages and advocacy stronger. Here are recent letters we have signed with others on access to medicines and COVID-19 – a crucial public health matter in these times.

Access to Medicines

April 7, 2020: Make vaccines, treatments and diagnostics related to the COVID-19 pandemic that are developed with public funding accessible at affordable cost to everyone worldwide – a letter from student organisation Universities Allied for Essential Medicines Netherlands (UAEM NL) to the Dutch government and the Netherlands Federation of University Medical Centres (NFU).

March 27, 2020: Open letter to the World Health Organization (WHO) and its Member States on the proposal by Costa Rica to create a global pool for rights in the data, knowledge and technologies useful in the prevention, detection and treatment of the coronavirus/COVID-19 pandemic – with this open letter to the World Health Organization and its member states, Wemos and other organisations and individuals show support for Costa Rica’s proposal for a global pooling mechanism of rights to address the COVID-19 pandemic.

March 25, 2020: The fight against COVID-19: let’s make public investments count for people – 61 organisations (including Wemos), consisting of patients, consumers, healthcare professionals, trade unions and public interest organisations express views on the importance of the role of public support to research and development during the current global pandemic.

*This article has been updated since its publication date

Photo credits: Jens Mahnke via Pexels

Recent News items

2019: our eventful year in review!

28-05-2020

We are proud to present Wemos’ year overview 2019. As last year also marked our 40th anniversary, it was a special year that gave us the opportunity to look back on our history, and see how far we’ve come as an organisation. Want to find out about our programmes’ achievements, many media appearances, new collaborations and how we celebrated our 40th birthday? Head on over to our new interactive document!

Continue reading